Sweeping restrictions on abortion across the U.S. have already had major ripple effects in reproductive health care. During president-elect Donald Trump’s next administration, restrictions on abortion ...

Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...

Starting in November 2024, McKenzie Rieder, a pediatric nurse practitioner for Mountain Family Health Centers in Glenwood Springs, noticed a trend: More young women were asking for long-acting ...

While physicians say long-term reversible birth control can lead to better health outcomes for new mothers, hospitals often face financial barriers when rolling out these programs, according to The ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety and ...

With several birth control options available, doctors say some methods are more effective than others and have different side ...

The teen birth rate in the U.S. has been declining consistently for more than 30 years, despite the fact that the number of teenage girls having sex has not changed since at least 2002. A new report ...

Birth control effectiveness varies by method, with implants, IUDs, and sterilization preventing pregnancy over 99% of the time. Pills, patches, and condoms are also reliable but depend more on correct ...